ArticleClinical kidney journal2026
Key predictors of mortality in profound hyponatremia beyond the correction rate.
Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Current guidelines for hyponatremia recommend slow sodium correction; however, recent large-scale observational studies have associated slow correction with increased mortality. The association between correction rate and mortality can be influenced by numerous factors, including comorbidities, overall condition, and treatment interventions, but this complex interplay remains unclear. We aimed to clarify this association by developing interpretable machine-learning models using detailed clinical features. Methods: We included 546 patients with serum sodium ≤120 mEq/l, collected clinical features through chart review, and developed four machine-learning models to predict in-hospital mortality. The best-performing model, selected by the area under the receiver operating characteristic curve (ROC-AUC), was interpreted using SHapley Additive exPlanations (SHAP) to quantify each feature's contribution to mortality prediction. Results: In-hospital mortality was 18%. The random forest model demonstrated the best predictive performance (ROC-AUC = 0.907; 95% confidence interval, 0.832-0.965). SHAP analysis revealed that the most influential predictors were baseline characteristics reflecting underlying illness severity: serum albumin, C-reactive protein, Charlson comorbidity index, and metastatic malignancy; their predictive effects were consistent across correction rates. Among treatment-related features, intravenous fluid choice and sodium monitoring frequency had a greater predictive impact than correction rate. Although slower correction was associated with higher mortality, the correction rate ranked 14th among all 59 features in predictive importance. Conclusions: In profound hyponatremia, multiple key predictors of mortality exist beyond the correction rate. These findings suggest that the observed association between slow correction and higher mortality may not be causal but rather an epiphenomenon driven by underlying illness severity and treatment intensity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.